These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2823321)

  • 1. Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin.
    Nicholson WE; DeCherney GS; Jackson RV; Orth DN
    Regul Pept; 1987 Aug; 18(3-4):173-88. PubMed ID: 2823321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
    Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
    van de Pavert SA; Clarke IJ; Rao A; Vrana KE; Schwartz J
    J Endocrinol; 1997 Jul; 154(1):139-47. PubMed ID: 9246948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ovine fetal pituitary function by corticotrophin-releasing hormone, arginine vasopressin and cortisol in vitro.
    Lü F; Yang K; Challis JR
    J Endocrinol; 1994 Oct; 143(1):199-208. PubMed ID: 7964318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides.
    Margioris AN; Grino M; Protos P; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1988 May; 66(5):922-6. PubMed ID: 2834412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and immunological characterization of corticotropin-releasing activity in the bovine adrenal medulla.
    Minamino N; Uehara A; Arimura A
    Peptides; 1988; 9(1):37-45. PubMed ID: 2834703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of corticotropin-releasing hormone and arginine vasopressin responsiveness during late-gestation pregnancy in sheep.
    Young SF; Rose JC
    Biol Reprod; 2002 Jun; 66(6):1805-12. PubMed ID: 12021066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine alterations in nude mice with a human lung carcinoma producing pro-opiomelanocortin, corticotrophin-releasing hormone and arginine vasopressin.
    Morano MI; de Antueno RJ; Niedfeld G; Estivariz FE
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):349-62. PubMed ID: 2160874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P; Anisman H; Merali Z
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice.
    Fukuda Y; Kageyama K; Nigawara T; Kasagi Y; Suda T
    Neurosci Lett; 2004 Sep; 367(2):201-4. PubMed ID: 15331153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors.
    Schmidt ED; Aguilera G; Binnekade R; Tilders FJ
    Neuroscience; 2003; 116(1):275-83. PubMed ID: 12535959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor.
    Liu J; Heikkilä P; Voutilainen R; Karonen SL; Kahri AI
    Eur J Endocrinol; 1994 Sep; 131(3):221-8. PubMed ID: 7921204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep.
    Currie IS; Brooks AN
    J Dev Physiol; 1992 May; 17(5):241-6. PubMed ID: 1281183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides related to the N-terminus of pro-opiomelanocortin in the human adrenal medulla.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1989 Apr; 12(2):90-8. PubMed ID: 2539931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone.
    Parsadaniantz SM; Batsché E; Gegout-Pottie P; Terlain B; Gillet P; Netter P; Kerdelhué B
    Neuroendocrinology; 1997 Jan; 65(1):53-63. PubMed ID: 9032774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational processing of pro-opiomelanocortin in the Brattleboro (di/di) rat pituitary.
    Canny BJ; Smith AI; Clements JA; Funder JW
    Neuroendocrinology; 1988 Dec; 48(6):603-10. PubMed ID: 2855104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.